Disability Buy-Sell Insurance

Disability buy-sell insurance is a type of insurance that helps business owners protect their business in case one of the owners becomes disabled. This insurance is designed to provide funding to buy out a disabled owner's share of the business.  

Here are some key features of disability buy-sell insurance:

  • It is typically purchased by co-owners of a business to protect the business in case one of them becomes disabled.
  • The policy pays out a lump sum benefit to the business owners if one of them becomes disabled and is unable to work.
  • The policy can be structured as either a cross-purchase plan or a redemption plan. In a cross-purchase plan, each owner purchases a policy on the other owners. In a redemption plan, the business itself purchases a policy on each owner.
  • The policy benefit amount is usually based on the value of the disabled owner's share of the business.
  • The policy may have a waiting period before benefits are paid, typically ranging from 30 to 180 days.
  • The policy may also have a benefit period, which is the length of time that benefits will be paid out if the disabled owner remains unable to work.
  • The premium for the policy is generally tax-deductible as a business expense, and the benefits paid out are generally tax-free to the recipient.

Here's an example: Suppose that three co-owners of a business purchase disability buy-sell insurance policies on each other. Each policy has a benefit amount of $500,000, and the policies are structured as a cross-purchase plan. If one of the owners becomes disabled and is unable to work, the other two owners would receive a total benefit of $500,000 to buy out the disabled owner's share of the business. The policy has a waiting period of 90 days and a benefit period of two years.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.